STE STERIS plc

  1. Stocks
  2. Healthcare
  3. NYSE: STE

Price (delayed)

$200.81

Market cap

$19.84B

P/E Ratio

35.17

Dividend/share

$2.03

EPS

$5.71

Enterprise value

$23.16B

Steris Corporation is an American Irish-domiciled medical equipment company specializing in sterilization and surgical products for the US healthcare system. Steris is operationally headquartered in Mentor, Ohio, but has been ...

Highlights
STE's P/E is 68% below its last 4 quarters average of 110.7 and 45% below its 5-year quarterly average of 64.4
The revenue has grown by 13% YoY and by 3.4% from the previous quarter
STERIS's debt has increased by 8% YoY but it has decreased by 3.4% from the previous quarter
STERIS's quick ratio has decreased by 7% YoY and by 3.8% from the previous quarter
STERIS's gross margin has decreased by 2.7% YoY
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: https://www.steris.com/
Peers: SYK TMO OMI CNMD

Key stats

What are the main financial stats of STE
Market
Shares outstanding
98.81M
Market cap
$19.84B
Enterprise value
$23.16B
Valuations
Price to earnings (P/E)
35.17
Price to book (P/B)
3.09
Price to sales (P/S)
3.67
EV/EBIT
28.23
EV/EBITDA
16.62
EV/Sales
4.28
Earnings
Revenue
$5.41B
EBIT
$820.16M
EBITDA
$1.39B
Free cash flow
$603.79M
Per share
EPS
$5.71
Free cash flow per share
$6.11
Book value per share
$64.93
Revenue per share
$54.73
TBVPS
$43.89
Balance sheet
Total assets
$11.44B
Total liabilities
$5.01B
Debt
$3.51B
Equity
$6.42B
Working capital
$1.31B
Liquidity
Debt to equity
0.55
Current ratio
2.43
Quick ratio
1.27
Net debt/EBITDA
2.38
Margins
EBITDA margin
25.8%
Gross margin
43.6%
Net margin
10.5%
Operating margin
15.1%
Efficiency
Return on assets
5.1%
Return on equity
9.1%
Return on invested capital
12.8%
Return on capital employed
7.8%
Return on sales
15.2%
Dividend
Dividend yield
1.01%
DPS
$2.03
Payout ratio
35.6%

STE stock price

How has the STERIS stock price performed over time
Intraday
0.28%
1 week
-2.65%
1 month
-12.69%
1 year
9.27%
YTD
-8.66%
QTD
-10.68%

Financial performance

How have STERIS's revenue and profit performed over time
Revenue
$5.41B
Gross profit
$2.36B
Operating income
$816.3M
Net income
$566.84M
Gross margin
43.6%
Net margin
10.5%
The revenue has grown by 13% YoY and by 3.4% from the previous quarter
STE's gross profit is up by 10% year-on-year and by 3.6% since the previous quarter
The company's net income rose by 3.1% QoQ
STE's operating income is up by 3.2% from the previous quarter

Growth

What is STERIS's growth rate over time

Valuation

What is STERIS stock price valuation
STE P/E details
P/E
35.17
P/B
3.09
P/S
3.67
EV/EBIT
28.23
EV/EBITDA
16.62
EV/Sales
4.28
STE's P/E is 68% below its last 4 quarters average of 110.7 and 45% below its 5-year quarterly average of 64.4
The company's EPS rose by 3.3% QoQ
STE's P/B is 12% below its 5-year quarterly average of 3.5 and 9% below its last 4 quarters average of 3.4
The company's equity rose by 6% YoY and by 3.8% QoQ
The P/S is 18% below the 5-year quarterly average of 4.5 and 10% below the last 4 quarters average of 4.1
The revenue has grown by 13% YoY and by 3.4% from the previous quarter

Efficiency

How efficient is STERIS business performance
STERIS's ROA has increased by 2% from the previous quarter

Dividends

What is STE's dividend history
Dividend details
DPS
$2.03
Dividend yield
1.01%
Payout ratio
35.6%
Recent dividends

Financial health

How did STERIS financials performed over time
The total assets is 128% more than the total liabilities
STERIS's quick ratio has decreased by 7% YoY and by 3.8% from the previous quarter
The total assets has grown by 6% YoY
STERIS's debt is 45% less than its equity
STERIS's debt has increased by 8% YoY but it has decreased by 3.4% from the previous quarter
STE's debt to equity is down by 7% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.